Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis

Emily J. Kirsch, Russell T. Greene, Annalisa Prahl, Stanley I. Rubin, Jane E Sykes, Michelle M. Durkin, Lawrence J. Wheat

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Antigen detection has been reported to be a promising method for rapid diagnosis of coccidioidomycosis in humans. Coccidioides antigen detection has not been previously reported in dogs with coccidioidomycosis and was evaluated in 60 cases diagnosed based on detection of anti-Coccidioides antibodies at titers of 1:16 or more in serum. Controls included dogs with presumed histoplasmosis or blastomycosis, other fungal infections, or nonfungal diseases and healthy dogs. Urine and serum specimens were tested using an enzyme immunoassay for Coccidioides galactomannan antigen. Antibody testing was performed at commercial veterinary reference laboratories. Antigen was detected in urine or serum of 12 of 60 (20.0%), urine only in 2 of 57 (3.5%), and serum only in 11 of 58 (19.0%) dogs with coccidioidomycosis. Antigen was detected in the urine of 3 of 43 (7.0%) and serum of 1 of 37 (2.7%) dogs with histoplasmosis or blastomycosis but not in 13 dogs with other fungal infections (serum, 9; urine, 13), 41 dogs with nonfungal diseases (urine, 41; serum, 18), or healthy dogs (serum, 21; urine, 21). Detection of antigen was an insensitive method for diagnosis of coccidioidomycosis in dogs in which the diagnosis was based primarily upon detection of antibodies at titers of 1:16 or higher, and the highest sensitivity was in serum.

Original languageEnglish (US)
Pages (from-to)343-345
Number of pages3
JournalClinical and Vaccine Immunology
Volume19
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Coccidioides
Coccidioidomycosis
Dogs
Antigens
Urine
Serum
Blastomycosis
Antibodies
Histoplasmosis
Mycoses
Dog Diseases
Immunoenzyme Techniques
Anti-Idiotypic Antibodies
Testing
Enzymes

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Kirsch, E. J., Greene, R. T., Prahl, A., Rubin, S. I., Sykes, J. E., Durkin, M. M., & Wheat, L. J. (2012). Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. Clinical and Vaccine Immunology, 19(3), 343-345. https://doi.org/10.1128/CVI.05631-11

Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. / Kirsch, Emily J.; Greene, Russell T.; Prahl, Annalisa; Rubin, Stanley I.; Sykes, Jane E; Durkin, Michelle M.; Wheat, Lawrence J.

In: Clinical and Vaccine Immunology, Vol. 19, No. 3, 03.2012, p. 343-345.

Research output: Contribution to journalArticle

Kirsch, EJ, Greene, RT, Prahl, A, Rubin, SI, Sykes, JE, Durkin, MM & Wheat, LJ 2012, 'Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis', Clinical and Vaccine Immunology, vol. 19, no. 3, pp. 343-345. https://doi.org/10.1128/CVI.05631-11
Kirsch, Emily J. ; Greene, Russell T. ; Prahl, Annalisa ; Rubin, Stanley I. ; Sykes, Jane E ; Durkin, Michelle M. ; Wheat, Lawrence J. / Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. In: Clinical and Vaccine Immunology. 2012 ; Vol. 19, No. 3. pp. 343-345.
@article{573d9418b2ec4ffd8ab12fcf3b87f332,
title = "Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis",
abstract = "Antigen detection has been reported to be a promising method for rapid diagnosis of coccidioidomycosis in humans. Coccidioides antigen detection has not been previously reported in dogs with coccidioidomycosis and was evaluated in 60 cases diagnosed based on detection of anti-Coccidioides antibodies at titers of 1:16 or more in serum. Controls included dogs with presumed histoplasmosis or blastomycosis, other fungal infections, or nonfungal diseases and healthy dogs. Urine and serum specimens were tested using an enzyme immunoassay for Coccidioides galactomannan antigen. Antibody testing was performed at commercial veterinary reference laboratories. Antigen was detected in urine or serum of 12 of 60 (20.0{\%}), urine only in 2 of 57 (3.5{\%}), and serum only in 11 of 58 (19.0{\%}) dogs with coccidioidomycosis. Antigen was detected in the urine of 3 of 43 (7.0{\%}) and serum of 1 of 37 (2.7{\%}) dogs with histoplasmosis or blastomycosis but not in 13 dogs with other fungal infections (serum, 9; urine, 13), 41 dogs with nonfungal diseases (urine, 41; serum, 18), or healthy dogs (serum, 21; urine, 21). Detection of antigen was an insensitive method for diagnosis of coccidioidomycosis in dogs in which the diagnosis was based primarily upon detection of antibodies at titers of 1:16 or higher, and the highest sensitivity was in serum.",
author = "Kirsch, {Emily J.} and Greene, {Russell T.} and Annalisa Prahl and Rubin, {Stanley I.} and Sykes, {Jane E} and Durkin, {Michelle M.} and Wheat, {Lawrence J.}",
year = "2012",
month = "3",
doi = "10.1128/CVI.05631-11",
language = "English (US)",
volume = "19",
pages = "343--345",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis

AU - Kirsch, Emily J.

AU - Greene, Russell T.

AU - Prahl, Annalisa

AU - Rubin, Stanley I.

AU - Sykes, Jane E

AU - Durkin, Michelle M.

AU - Wheat, Lawrence J.

PY - 2012/3

Y1 - 2012/3

N2 - Antigen detection has been reported to be a promising method for rapid diagnosis of coccidioidomycosis in humans. Coccidioides antigen detection has not been previously reported in dogs with coccidioidomycosis and was evaluated in 60 cases diagnosed based on detection of anti-Coccidioides antibodies at titers of 1:16 or more in serum. Controls included dogs with presumed histoplasmosis or blastomycosis, other fungal infections, or nonfungal diseases and healthy dogs. Urine and serum specimens were tested using an enzyme immunoassay for Coccidioides galactomannan antigen. Antibody testing was performed at commercial veterinary reference laboratories. Antigen was detected in urine or serum of 12 of 60 (20.0%), urine only in 2 of 57 (3.5%), and serum only in 11 of 58 (19.0%) dogs with coccidioidomycosis. Antigen was detected in the urine of 3 of 43 (7.0%) and serum of 1 of 37 (2.7%) dogs with histoplasmosis or blastomycosis but not in 13 dogs with other fungal infections (serum, 9; urine, 13), 41 dogs with nonfungal diseases (urine, 41; serum, 18), or healthy dogs (serum, 21; urine, 21). Detection of antigen was an insensitive method for diagnosis of coccidioidomycosis in dogs in which the diagnosis was based primarily upon detection of antibodies at titers of 1:16 or higher, and the highest sensitivity was in serum.

AB - Antigen detection has been reported to be a promising method for rapid diagnosis of coccidioidomycosis in humans. Coccidioides antigen detection has not been previously reported in dogs with coccidioidomycosis and was evaluated in 60 cases diagnosed based on detection of anti-Coccidioides antibodies at titers of 1:16 or more in serum. Controls included dogs with presumed histoplasmosis or blastomycosis, other fungal infections, or nonfungal diseases and healthy dogs. Urine and serum specimens were tested using an enzyme immunoassay for Coccidioides galactomannan antigen. Antibody testing was performed at commercial veterinary reference laboratories. Antigen was detected in urine or serum of 12 of 60 (20.0%), urine only in 2 of 57 (3.5%), and serum only in 11 of 58 (19.0%) dogs with coccidioidomycosis. Antigen was detected in the urine of 3 of 43 (7.0%) and serum of 1 of 37 (2.7%) dogs with histoplasmosis or blastomycosis but not in 13 dogs with other fungal infections (serum, 9; urine, 13), 41 dogs with nonfungal diseases (urine, 41; serum, 18), or healthy dogs (serum, 21; urine, 21). Detection of antigen was an insensitive method for diagnosis of coccidioidomycosis in dogs in which the diagnosis was based primarily upon detection of antibodies at titers of 1:16 or higher, and the highest sensitivity was in serum.

UR - http://www.scopus.com/inward/record.url?scp=84857977850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857977850&partnerID=8YFLogxK

U2 - 10.1128/CVI.05631-11

DO - 10.1128/CVI.05631-11

M3 - Article

C2 - 22278324

AN - SCOPUS:84857977850

VL - 19

SP - 343

EP - 345

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 3

ER -